Ubs Group Ag Journey Medical Corp Transaction History

Ubs Group Ag

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$2.7 - $7.96 $32,186 - $94,891	11,921 Added 819.31%	13,376 $77,000
Q3 2023 Nov 09, 2023	SELL	$1.66 - $2.97 $697 - $1,247	-420 Reduced 22.4%	1,455 $3,000
Q2 2023 Aug 11, 2023	SELL	$1.03 - $2.26 $2,392 - $5,249	-2,323 Reduced 55.34%	1,875 $2,000
Q1 2023 May 12, 2023	BUY	$1.28 - $2.54 $5,373 - $10,662	4,198 New	4,198 $6,000
Q3 2022 Nov 10, 2022	SELL	$2.46 - $4.15 $3,062 - $5,166	-1,245 Reduced 46.3%	1,444 $4,000
Q2 2022 Aug 10, 2022	SELL	$2.62 - $5.06 $1,270 - $2,454	-485 Reduced 15.28%	2,689 $10,000
Q1 2022 May 16, 2022	SELL	$3.93 - $5.76 $290 - $426	-74 Reduced 2.28%	3,174 $15,000
Q4 2021 Feb 14, 2022	BUY	$5.17 - $9.9 $16,792 - $32,155	3,248 New	3,248 $17,000

2.93M

Ticker DERM
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 11,596,500
Market Cap $44.1M
Description
Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.